Waters Collaborates with BTI on Glycosphingolipid Project
Waters Corporation has announced a collaboration with the Bioprocessing Technology Institute (BTI), a research institute within Singapore’s Agency for Science, Technology, and Research.
Waters Corporation (Massachusetts, USA) has announced a collaboration with the Bioprocessing Technology Institute (BTI), a research institute within Singapore’s Agency for Science, Technology, and Research (A*STAR).
The joint effort will develop a glycosphingolipid (GSL) head group database containing Glucose Unit (GU) retention times1 and collision cross-section (CCS) values, forming an experimental library for diseaseârelated GSL glycans together with a glycan/MS spectral library.
GSLs constitute a glycan head group attached to fatty acyl moieties, and are critical for cell growth interaction, and signalling. Alterations to their structure can cause disease or promote cancer development, however, analysis of glycan head groups has proved difficult because their isomeric structures are not easily differentiated by either liquid chromatography (LC) or mass spectrometry (MS) when used alone.
“Collaborating with Waters will enable BTI to apply its expertise in glycomics to develop analytical methods and a library of information on GSLs that doesn’t yet exist today. This will allow us to probe for potential clinical markers and to provide insights into disease progression and regression following therapeutic intervention,” said Dr. Susanto Woen, Research Scientist, BTI.
A key aim of the project is new therapeutic strategies for the detection of cancer markers through a deeper understanding of glycosylation pathways but significant technological advancements are also expected.
“The partnership allows us to be part of an international glycomics research network pioneering technologies required to determine the potential association between GSL glycosylation and any phenotypic/genotypic traits in disease or disease states,” continued Woen.
As part of the collaboration, Waters will contribute scientific expertise and use of its analytical systems. For more information please visit www.waters.com
Reference
- S. Albrecht et al., Anal. Chem.88(9), 4795–4802 (2016) DOI:10.1021/acs.analchem.6b00259.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
